Biomarin Pharmaceutical Inc

Covea Finance BMRN
Report date
3/31/2026
Quarter
2026 Q1
Filed
4/15/2026
Shares
140,500
Value ($000)
7,937
Weight
0.3%
2025 Q2 - 2026 Q1 (4 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).